Secondary Sjögren's in patients with systemic scleroderma
https://doi.org/10.33667/2078-5631-2019-3-23(398)-37-39
Abstract
The aim of the study was to investigate the morphological differences of the minor salivary glands in patients with secondary Sjögren's syndrome associated with systemic scleroderma (Scl-SS). Total of 40 patients were grouped according to the American–European Consensus Group criteria. Information about the duration of the disease was taken from the patients records. Sections of the minor salivary gland biopsy were reevaluated, and the lymphocyte focus score (FS), plasma cell focus, and fibrosis rates were all evaluated. The groups were formed according to the duration of the disease: less than and over 5 years.
Results. Scl-SS leads to changes in both in the large salivary glands and in the MSG, manifested in the form of mucoid swelling, fibrinoid changes, hyalinosis and sclerosis. In patients with Scl-SS the progression of the process leads to the destruction of the duct wall and to the focal and diffuse lymphoid infiltration.
About the Authors
E. I. Selifanova
First Moscow State Medical University
Russian Federation
Russian Federation
Moscow
M. S. Esayan
First Moscow State Medical University
Russian Federation
Russian Federation
Moscow
References
1. Гусева Н. Г. Системная склеродермия — мультидисциплинарная проблема. Научно-практическая ревматология; 2011; № 2; 10–14.
2. Baron M, Hudson M, Tatibouet S. et. al. Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III. Arthritis Care Res (Hoboken). 2015 May; 67 (5): 681–90. doi.org/10.1002/acr.22490.
3. Knaś M, Zalewska A, Waszkiewicz N, Szulimowska J et. al. Salivary: flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis. J Oral Pathol Med. 2014 Aug; 43 (7): 521–9. doi.org/10.1111/jop.12166.
4. Афанасьев В. В., Красникова Т. В., Яглова Н. В. Ультраструктурные изменения малых слюнных желез у больных с различными формами сиаладеноза. Российская стоматология. 2014; 7 (1): 31–33.
5. Streifler JY, Molad Y. Connective tissue disorders: Systemic lupus erythematosus, sjögren's syndrome, and scleroderma. Handb Clin Neurol 2014; 119: 463–73.
6. Maślińska M, Przygodzka M, Kwiatkowska B, Sikorska-Siudek K. Sjögren's syndrome: Still not fully understood disease. Rheumatol Int 2015; 35: 233–41. doi.org/10.1007/s00296–014–3072–5.
7. Al-Hashimi I, Wright JM, Cooley CA, Nunn ME. Reproducibility of biopsy grade in Sjögren's syndrome. J Oral Pathol Med 2001; 30: 408–412. doi.org/10.1034/j.1600–0714.2001.300705.x.
8. Stewart CM, Bhattacharyya I, Berg K, Cohen DM, Orlando C, Drew P, et al. Labial salivary gland biopsies in sjögren's syndrome: Still the gold standard? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 392–402 doi.org/10.1016/j.tripleo.2008.04.018.
9. Ulku K, Sulen S, Pinar C, Ismail S, Merih B. Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma. Indian journal of pathology and microbiology, 2018; Volume 61; Issue 3; Page: 319–322. doi.org/10.4103/ijpm.ijpm_416_17.
10. Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg JE, Mariette X. Sjogren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford). 2007 Feb; 46 (2): 321–6. Epub 2006 Jul. doi.org/10.1093/rheumatology/kel252.
Review
For citations:
Selifanova E.I., Esayan M.S. Secondary Sjögren's in patients with systemic scleroderma. Medical alphabet. 2019;3(23):37-39. (In Russ.) https://doi.org/10.33667/2078-5631-2019-3-23(398)-37-39
Views:
1005
Email this article 